Barclays PLC — Major Shareholding Notification 2021

Jun 17, 2021

National Storage Mechanism | Additional information

Form 8.3 - WILLIS TOWERS WATSON PLC

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

	Name of person dealing (Note 1)	Barclays PLC.
	Company dealt in	WILLIS TOWERS WATSON PLC
	Class of relevant security to which the	ORD
	dealings being disclosed relate (Note 2)
	Date of dealing	15 June 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:		ORD
		Long		Short
		Number	(%)	Number	(%)
(1)	Relevant securities
		1,894,589	1.47%	233,108	0.18%
(2)	Derivatives (other than options):
		72,359	0.06%	94,581	0.07%
(3)	Options and agreements to
	purchase/sell:	6,100	0.00%	6,100	0.00%
	TOTAL:
		1,973,048	1.53%	333,789	0.26%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long			Short
	Number		(%)	Number		(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit
Purchase	2	256.2850 USD
Purchase	4	257.9800 USD
Purchase	4	257.3500 USD
Purchase	10	255.3200 USD
Purchase	33	256.5300 USD
Purchase	66	256.6781 USD
Purchase	82	256.1200 USD
Purchase	92	255.3334 USD
Purchase	100	254.9200 USD
Purchase	100	255.0080 USD
Purchase	100	256.1800 USD
Purchase	135	255.3464 USD
Purchase	140	255.5550 USD
Purchase	150	255.9000 USD
Purchase	162	256.0728 USD
Purchase	200	256.8900 USD
Purchase	200	255.1650 USD
Purchase	240	255.3487 USD
Purchase	300	255.5800 USD
Purchase	400	255.3307 USD
Purchase	440	255.1330 USD
Purchase	500	255.3450 USD
Purchase	556	256.6081 USD
Purchase	624	257.0070 USD
Purchase	700	254.9857 USD
Purchase	700	255.6871 USD
Purchase	836	255.8816 USD
Purchase	1,402	255.0100 USD
Purchase	2,073	256.8778 USD
Purchase	2,216	256.1178 USD
Purchase	2,288	256.1445 USD
Purchase	2,522	256.2692 USD
Purchase	2,719	255.9627 USD
Purchase	3,386	255.5641 USD
Purchase	4,086	255.7388 USD
Purchase	4,513	256.4314 USD
Purchase	4,718	255.2218 USD
Purchase	5,770	255.6502 USD
Purchase	6,156	256.1104 USD
Purchase	6,606	255.4358 USD
Purchase	7,752	255.8503 USD
Purchase	13,226	256.8070 USD
Purchase	24,704	255.6000 USD
Purchase	32,711	255.9868 USD
Sale	1	256.5200 USD
Sale	8	257.3500 USD
Sale	19	256.8800 USD
Sale	35	256.5128 USD
Sale	82	256.1200 USD
Sale	92	257.7300 USD
Sale	100	256.4800 USD
Sale	200	256.4750 USD
Sale	200	255.2350 USD
Sale	900	257.1711 USD
Sale	1,120	256.2842 USD
Sale	1,305	255.5906 USD
Sale	1,340	256.3016 USD
Sale	1,689	256.1670 USD
Sale	1,722	256.2468 USD
Sale	1,852	256.6095 USD
Sale	2,078	256.1301 USD
Sale	2,674	255.6005 USD
Sale	3,164	256.3502 USD
Sale	3,431	255.6019 USD
Sale	3,678	256.3424 USD
Sale	3,909	256.3519 USD
Sale	6,480	255.7491 USD
Sale	10,000	255.1963 USD
Sale	21,673	255.6000 USD
Sale	30,000	256.1968 USD
Sale	35,176	255.9337 USD

(b) Derivatives transactions (other than options transactions)

Product name, e.g. CFD	Nature of transaction (Note 6)	Number of relevant securities (Note 7)	Price per unit (Note 5)

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name, e.g. call option	Writing, selling, purchasing, varying etc.	Number of securities to which the option relates (Note 7)	Exercise price	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 5)

(ii) Exercising

Product name, e.g. call option	Number of securities	Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)	Details	Price per unit (if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached?	YES
Date of disclosure:	17 Jun 2021
Contact name:	Large Holdings Regulatory Operations
Telephone number:	020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name	Written or	Number of	Exercise	Type	Expiry
	purchased	relevant securities	price		date
		to which the option
		or derivative
		relates
Put Options	Purchased	-100	220.0000	American	Jul 16, 2021
Call Options	Purchased	100	240.0000	American	Jul 16, 2021
Call Options	Purchased	6,000	220.0000	American	Jul 16, 2021
Put Options	Purchased	-6,000	200.0000	American	Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210617005343/en/

BARCLAYS PLC